November 15, 2021

UAMS Receives $18.9 Million NIH Award to Address Health Disparities

David Robinson

Members of the research team include, (back row, l-r) Keneshia Bryant-Moore, Ph.D., FNP-BC, RN, Pebbles Fagan, Ph.D., Carol Cornell, Ph.D., Linda Luster and Christina Hamilton; (front) Elizabeth Taylor, Theresa Prewitt, Dr.P.H., and Tiffany Haynes, Ph.D. Pictured separately are, from top: Mark Williams, Ph.D., Chris Long, Ph.D., and Mignonne Guy, Ph.D. (Virginia Commonwealth University).

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas. The five-year award from…

November 4, 2021

UAMS Receives Full Accreditation, Area of Distinction for its Human Research Protection Program

David Robinson

Edith Paal, M.S.Journ., MPH, is director of the UAMS Institutional Review Board (IRB), and Allen Sherman, Ph.D., is the board chair. The IRB reviews all research to ensure the protection of the rights and welfare of the people who are participating.

The University of Arkansas for Medical Sciences (UAMS) Human Research Protection Program was fully accredited recently for another five years by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). UAMS became one of the first 25 institutions in the United States to receive the accreditation in 2005 and has maintained it since…

November 1, 2021

NIH Awards $13.8 Million to Test UAMS-Discovered Drug for Methamphetamine Use Disorder Treatment

David Robinson

UAMS’ Brooks Gentry, M.D., is leading the study of what could become the first monoclonal antibody treatment for methamphetamine use disorder and overdose.

A drug discovered at the University of Arkansas for Medical Sciences (UAMS) to counter the effects of methamphetamine will be tested in a phase 2 clinical trial as the only potential treatment of its kind for methamphetamine use disorder.

October 28, 2021

UAMS Researchers See 12% Increase in Grant Funding for FY2021

David Robinson

As UAMS vice chancellor for Research and Innovation, Shuk-Mei Ho, Ph.D., oversees the institution's research enterprise.

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 12.2% this past year, with $177.4 million in grants by the end of the fiscal year on June 30. It is the second consecutive year with double-digit increases in research funding that comes from…

October 26, 2021

NCI Grant Supporting UAMS Research to Improve Cancer Treatment for Patients Lacking Good Gut Bacteria

David Robinson

UAMS’ Ruud P.M. Dings, Ph.D., hopes to improve treatment outcomes for cancer patients with an absence of good gut bacteria.

LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team will use a National Cancer Institute (NCI) grant to study promising new ways to improve the effectiveness of a common cancer treatment for patients lacking beneficial gut bacteria. The five-year, nearly $2 million grant is led by Ruud P.M. Dings, Ph.D., M.Sc., an…

September 29, 2021

UAMS Research Team Upends Understanding of How Blood Clots Form; NIH Awards $2.5 Million for Further Study

David Robinson

Brian Storrie, Ph.D., with members of the research team (standing, l-r), Kelly Ball, M.S., Sung Rhee, Ph.D., and Irina Pokrovskaya, M.S., displaying images of blood platelets that have combined to seal a puncture wound.

LITTLE ROCK — A UAMS-led research team has found that blood clots form in puncture wounds similar to a skyscraper, with rooms and furnishings that scientists can now see. Published in Communications Biology, the discovery of the vaulted thrombus (blood clot) structure surprised researchers and is a big change from a long-held hypothesis. The Sept….

September 9, 2021

UAMS Research Team Finds Potential Cause of COVID-19 ‘Long-haulers’

David Robinson

Terry Harville, M.D., Ph.D., consults with John Arthur, M.D., Ph.D., in the UAMS Pathology Lab.

LITTLE ROCK — A UAMS research team has identified a potential cause of long-lasting symptoms experienced by COVID-19 patients, often referred to as long-haulers. The findings were published in the journal, The Public Library of Science ONE (PLOS ONE). At the heart of the team’s findings is an antibody that shows up weeks after an…

August 19, 2021

UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana

David Robinson

Taren Swindle, Ph.D., here visiting a Head Start classroom in 2019, is leading the NCI-funded study that aims to improve diets in early care and education settings.

UAMS is leading a major new effort to reduce cancer by addressing eating habits in early childcare and education settings. The project, led by UAMS’ Taren Swindle, Ph.D., will reach about 5,000 children and 500 teachers across Arkansas and Louisiana.

July 21, 2021

Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team

David Robinson

Members of the UAMS proteomics team are Alan Tackett, Ph.D. (center front), and (l-r) Stephanie Byrum, Ph.D., Rick Edmondson, Ph.D., Aaron Storey, Ph.D., and Samuel Mackintosh, Ph.D.

LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…

July 20, 2021

UAMS Releases Findings from Statewide COVID-19 Antibody Study

David Robinson

A team at UAMS tested blood samples from July to December 2020 and found that by the end of the year, 7.4% of Arkansans had SARS-CoV-2 antibodies.

LITTLE ROCK — A statewide COVID-19 antibody study led by UAMS found that by the end of 2020, 7.4% of Arkansans had antibodies to the virus, but there were wide disparities among racial and ethnic groups. UAMS researchers released their findings this week to a public database, medRxiv (med archive).


Previous page Next page